When an adverse reaction to chemotherapy sent a patient into heart failure, it took state-of-the-art treatment from an advanced cardiovascular team to save him in time.
This year’s Meeting on the Mesa showed that cell and gene therapy is no longer defined by hype, but by hard work– from digital manufacturing to creative funding models and policy alignment.
Air Force reviews cancer risk in missile crews; early analyses show no excess mortality, but exposures to PCBs and benzene prompt vigilance and targeted histories.